Skip to main page content

Dr. Mona Harissi-Dagher

Chair, COS Annual Meeting
Participates in 11 items

Dr. Dagher is professor of ophthalmology at the Université de Montréal, and head of the department of ophthalmology at Centre Hospitalier de l’Université de Montréal (CHUM). Dr. Dagher is chair of the annual meeting of the Canadian Ophthalmologic Society (COS) and has served as Board member of COS since 2012.


Dr. Dagher enjoys teaching medical students, ophthalmology residents and clinical and research cornea fellows as well as training MSc and PhD students as well.
Dr. Dagher completed her undergraduate degree at McGill University where she received the Hilda Diana Oakley scholarship for ranking top female student at McGill. She then completed her medical degree and specialization in ophthalmology at Université de Montréal, graduating on the dean’s honor list. Dr. Dagher then pursued post-doctoral fellowship training in cornea, external eye diseases, and refractive surgery at the Massachusetts Eye and Ear Infirmary, Harvard Medical School.
 

Dr. Dagher has brought her expertise on keratoprosthesis surgery to Canada after conducting considerable research and clinical work at Harvard Medical School under the mentorship of Dr Claes Dohlman. After restoring sight to several Canadian patients through implantation of the Boston Keratoprosthesis, Dr. Dagher was chosen ‘Personality of the Week’ by La Presse and Radio-Canada.


Dr. Dagher has completed extensive research in the field of ophthalmology and more particularly, on the Boston Keratoprosthesis and on refractive surgery. Dr. Dagher has published numerous articles and acts as a reviewer for many ophthalmology journals. She has also authored numerous book chapters about cornea and external eye diseases. Dr. Dagher has been a guest lecturer at ophthalmology conferences internationally.
 

Financial disclosure: Dr. Harissi-Dagher has/had an affiliation (financial or otherwise) with a commercial organization:
1. Sun Pharma

Sessions in which Dr. Mona Harissi-Dagher participates

Friday 10 June, 2022

Time Zone: (GMT-04:00) Atlantic Time (Canada)
8:00 AM - 10:00 AM | 2 hours
Current Concepts
8:06 AM - 8:10 AM | 4 minutes
Current Concepts
1:30 PM - 3:00 PM | 1 hour 30 minutes
Cornea
4:45 PM - 4:50 PM | 5 minutes
EDI

Saturday 11 June, 2022

Time Zone: (GMT-04:00) Atlantic Time (Canada)
8:00 AM - 10:00 AM | 2 hours
Current Concepts
8:00 AM - 8:02 AM | 2 minutes
Current Concepts
1:30 PM - 3:00 PM | 1 hour 30 minutes
Skills Transfer Course (STC)
1:49 PM - 1:55 PM | 6 minutes
Skills Transfer Course (STC)

Sunday 12 June, 2022

Time Zone: (GMT-04:00) Atlantic Time (Canada)
8:00 AM - 10:00 AM | 2 hours
Current Concepts
8:00 AM - 8:02 AM | 2 minutes
Current Concepts

Sessions in which Dr. Mona Harissi-Dagher attends

Thursday 9 June, 2022

Time Zone: (GMT-04:00) Atlantic Time (Canada)

Friday 10 June, 2022

Time Zone: (GMT-04:00) Atlantic Time (Canada)
6:30 AM - 8:00 AM | 1 hour 30 minutes
Women in Ophthalmology
10:45 AM - 12:15 PM | 1 hour 30 minutes
Cornea
12:15 PM - 1:30 PM | 1 hour 15 minutes
Special Event
Session Chair
3:45 PM - 5:15 PM | 1 hour 30 minutes
Cornea
6:30 PM - 10:00 PM | 3 hours 30 minutes

Saturday 11 June, 2022

Time Zone: (GMT-04:00) Atlantic Time (Canada)
6:30 AM - 8:00 AM | 1 hour 30 minutes
Co-Developed Symposium

Innovation in Retina Research Award Learning ObjectivesAt the end of this symposium, participants will be able to:Identify innovative Canadian retina research proposals and their intended benefitDescribe how using digital innovations in ophthalmology can optimize patie...

10:45 AM - 12:15 PM | 1 hour 30 minutes
Cornea
12:15 PM - 1:30 PM | 1 hour 15 minutes
Keynote Speaker
Keynote Speaker
1:30 PM - 3:00 PM | 1 hour 30 minutes
Skills Transfer Course (STC)
1:30 PM - 3:00 PM | 1 hour 30 minutes
Cataract
1:30 PM - 3:00 PM | 1 hour 30 minutes
Ocular Regenerative Medicine
3:45 PM - 5:15 PM | 1 hour 30 minutes
Cataract

Sunday 12 June, 2022

Time Zone: (GMT-04:00) Atlantic Time (Canada)
6:30 AM - 8:00 AM | 1 hour 30 minutes
Co-Developed Symposium

LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...